M. Zafar, MD, SC, is a leading internal medicine practice serving the Central Illinois community and beyond with offices in Streator and Flanagan. The practice is led by Muhammad Zafar, MD, who has over fifty years of experience working as a board-certified physician.

Dr. Zafar obtained his medical degree from King Edward Medical University in Lahore, Pakistan, in 1969. He completed his post-medical residency in Internal Medicine and fellowships in Hematology and Oncology at Cook County Hospital in Chicago, Illinois.

Patients trust Dr. Zafar because he has an extensive knowledge base and practical experience treating patients with various illnesses. M. Zafar, MD, SC, offers oncology care for blood cancers and other hematological malignancies. In addition to hematology, the practice provides medical weight loss support with Semaglutide (the active ingredient of Ozempic™ and Wegovy™) and Tirzepatide (the active ingredient of Mounjaro™). 

Dr. Zafar is a highly skilled physician who truly believes in being available to patients and their families. He is dedicated to staying up to date with trends in modern medicine to deliver patient care based on the latest research.

In his free time, Dr. Zafar enjoys watching the Chicago Bulls and Bears, gardening, and spending time with his grandchildren.

Revitalize your health journey with the comprehensive medical weight loss services at M. Zafar, MD, SC, serving Illinois statewide by Telehealth. Led by Dr. Muhammad Zafar, MD, the practice offers personalized and innovative weight loss strategies, including the use of Semaglutide (the active ingredient of Ozempic™ and Wegovy™) and Tirzepatide (the active ingredient of Mounjaro™). At M. Zafar, MD, SC, we strive to foster an environment where patients feel heard, understood, and confident in their health journey. Trust us to be your partner in health, paving the path to well-being through superior medical care.

Our gola is to have ALL CGM devices on our platform. Broadly speaking, health systems have interest in supporting data collection from devices their patients are already using, especially while supporting chronic conditions such as diabetes. Long-term, Locus will offer normalized views and consistent integration experiences for many more devices. Ideally, with large enough data sets, we will be able to leverage innovations in AI Healthcare Co-pilots to support clinical staff in minimizing delays, increasing efficiency, and improving remote patient monitoring outcomes. In the longer term, we intend to be a key partner in all of our health systems’ population health engines. 

Strategically, Locus is focused on: 

(1) helping our customer health systems leverage the critical investment they’ve made in existing technology platforms like the EHR, creating impact for key patient populations where remote care management can most effectively drive outcomes and return on investment. 

(2) meeting our health system care teams where they are, recognizing the reality of patient monitoring and navigation needs vs available provider resources and ensuring that our platform’s ability to collect, synthesize, and transmit key population and patient-specific data supports the efficiency of their teams’ workflows and innovative approaches to coordinated care. 

(3) providing a single-platform “middleware plus” approach to integration, allowing health system teams to choose their preferred remote devices and seamlessly integrate with other relevant patient information via Locus to the EHR 

(4) helping our health system customers view and establish Remote Care Management (both RPM and Navigation) as a strategic capability, supporting both enhanced quality outcomes and becoming a positive-ROI profit center (via enhanced reimbursement revenue and/or lower preventable costs).